Rocket Lab's shares have dropped 64% since May, reflecting investor concerns despite strong operational growth. The company now earns most revenue from spacecraft manufacturing rather than launches, with a backlog growing faster than revenue. Its planned acquisition of Iridium could add recurring satellite communications revenue, but delays in the Neutron rocket and increased financing needs raise risks. Upcoming earnings on November 9 will be critical to assess if Rocket Lab can convert its expanding space infrastructure into sustainable profits.
Rocket Lab's stock trades at USD 55.83 on Pluang as of November 2, 2026, down 4.73% for the day. The company's market capitalization stands at $34.99 billion, reflecting significant investor interest despite recent volatility. Its 52-week price range on Pluang spans from $39.48 to $150.23, highlighting the stock's wide fluctuations this year.
Rocket Lab Corporation (RKLB) is still recommended as a buy despite an expected delay of nearly one year for its Neutron rocket. The delay reduces 2030 revenue estimates by $320 million and lowers the fair value per share by 14% to $86. However, secu...
Rocket Lab shares are forecasted to reach $100 by September 30, 2027, driven by the first flight of their Neutron rocket and a significant backlog increase. The company expects Neutron production and launch pad delivery in Q4 2026, with positive cash...
SpaceX's stock dropped 3% even after securing a $40 billion lease for NVIDIA GPUs and Fitch Ratings maintaining its BBB+ credit rating. The lease supports SpaceX's growing AI compute business, which now generates significant revenue but also shows cu...
